NEW YORK (GenomeWeb News) – Febit said today that it will collaborate with the Translational Genomics Research Institute to evaluate the use of Febit’s Geniom microarray technology in capturing DNA for next-generation sequencers.
 
TGen is Febit’s first US pilot user for the HybSelect technology, which the company said enables selective DNA capture and elution in order to pre-select sequences for next-generation platforms.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.